{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:49:09Z","timestamp":1791132549231,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.antiviral.2010.06.011","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T08:40:14Z","timestamp":1278405614000},"page":"295-306","source":"Crossref","is-referenced-by-count":36,"title":["Discovery of a novel TLR2 signaling inhibitor with anti-viral activity"],"prefix":"10.1016","volume":"87","author":[{"given":"Shenghua","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Cerny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glennice","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Knipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn A.","family":"Kurt-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Finberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.antiviral.2010.06.011_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.antiviral.2010.06.011_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2008-04-151712","article-title":"Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology","volume":"133","author":"Baenziger","year":"2008","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2010.06.011_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","article-title":"Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates","volume":"33","author":"Battegay","year":"1991","journal-title":"J. Virol. Methods"},{"issue":"8","key":"10.1016\/j.antiviral.2010.06.011_bib4","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/JVI.77.8.4588-4596.2003","article-title":"Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2","volume":"77","author":"Compton","year":"2003","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.antiviral.2010.06.011_bib5","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1021\/jm800957k","article-title":"Small molecule modulators of Toll-like receptors","volume":"51","author":"Czarniecki","year":"2008","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.antiviral.2010.06.011_bib6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1053\/j.gastro.2009.05.060","article-title":"Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C","volume":"137","author":"Dove","year":"2009","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.antiviral.2010.06.011_bib7","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.micinf.2004.08.013","article-title":"Viruses and Toll-like receptors","volume":"6","author":"Finberg","year":"2004","journal-title":"Microbes Infect."},{"issue":"2","key":"10.1016\/j.antiviral.2010.06.011_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.immuni.2009.02.001","article-title":"Antiviral responses: different roles for different tolls","volume":"30","author":"Finberg","year":"2009","journal-title":"Immunity"},{"issue":"6851","key":"10.1016\/j.antiviral.2010.06.011_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/35092578","article-title":"Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction","volume":"413","author":"Fitzgerald","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.antiviral.2010.06.011_bib10","first-page":"186","article-title":"Hypothesis tests","volume":"9","author":"Gauvreau","year":"1993","journal-title":"Nutrition"},{"issue":"12 Suppl.","key":"10.1016\/j.antiviral.2010.06.011_bib11","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges","volume":"10","author":"Geisbert","year":"2004","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.antiviral.2010.06.011_bib12","doi-asserted-by":"crossref","first-page":"e3725","DOI":"10.1371\/journal.pone.0003725","article-title":"Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin","volume":"3","author":"Gowen","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.antiviral.2010.06.011_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm1191","article-title":"Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7","volume":"11","author":"Hornung","year":"2005","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.antiviral.2010.06.011_bib14","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.0308057100","article-title":"Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis","volume":"101","author":"Kurt-Jones","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.antiviral.2010.06.011_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/80833","article-title":"Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus","volume":"1","author":"Kurt-Jones","year":"2000","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.antiviral.2010.06.011_bib16","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1371\/journal.ppat.0020053","article-title":"Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia","volume":"2","author":"Le Goffic","year":"2006","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.antiviral.2010.06.011_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0966-842X(00)01845-X","article-title":"The Toll receptor family and microbial recognition","volume":"8","author":"Medzhitov","year":"2000","journal-title":"Trends Microbiol."},{"issue":"3","key":"10.1016\/j.antiviral.2010.06.011_bib18","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1128\/JVI.00671-08","article-title":"Respiratory syncytial virus activates innate immunity through Toll-like receptor 2","volume":"83","author":"Murawski","year":"2009","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2010.06.011_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejphar.2007.05.013","article-title":"Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice","volume":"569","author":"Nakamura","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.antiviral.2010.06.011_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrd2070","article-title":"Targeting signal transduction as a strategy to treat inflammatory diseases","volume":"5","author":"O\u2019Neill","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.antiviral.2010.06.011_bib21","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1021\/jm050585d","article-title":"Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion. Synthesis and structure\u2013activity relationships","volume":"49","author":"Seyberth","year":"2006","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.antiviral.2010.06.011_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.antiviral.2010.06.011_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxh186","article-title":"Toll-like receptors in innate immunity","volume":"17","author":"Takeda","year":"2005","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.antiviral.2010.06.011_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","article-title":"Innate immunity to virus infection","volume":"227","author":"Takeuchi","year":"2009","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.antiviral.2010.06.011_bib25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1462-5822.2007.00961.x","article-title":"Innate immunity to respiratory viruses","volume":"9","author":"Wang","year":"2007","journal-title":"Cell. Microbiol."},{"issue":"12","key":"10.1016\/j.antiviral.2010.06.011_bib26","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/nm1140","article-title":"Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis","volume":"10","author":"Wang","year":"2004","journal-title":"Nat. Med."},{"issue":"23","key":"10.1016\/j.antiviral.2010.06.011_bib27","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1021\/jm050623t","article-title":"Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate","volume":"48","author":"Yamada","year":"2005","journal-title":"J. Med. Chem."},{"issue":"5844","key":"10.1016\/j.antiviral.2010.06.011_bib28","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1126\/science.1139522","article-title":"TLR3 deficiency in patients with herpes simplex encephalitis","volume":"317","author":"Zhang","year":"2007","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2010.06.011_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jneuroim.2007.11.018","article-title":"Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88\/Mal-dependent inflammatory responses","volume":"194","author":"Zhou","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.antiviral.2010.06.011_bib30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/eji.200425730","article-title":"MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection","volume":"35","author":"Zhou","year":"2005","journal-title":"Eur. J. Immunol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210006443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210006443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T19:58:33Z","timestamp":1544385513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354210006443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0166354210006443"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2010.06.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}